Navigation Links
Sunesis Pharmaceuticals Appoints Helen S. Kim to Board of Directors
Date:7/27/2009

SOUTH SAN FRANCISCO, Calif., July 27 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that Helen S. Kim has been appointed to the company's Board of Directors, effective immediately. Ms. Kim is a designee of New Enterprise Associates, which purchased approximately $2.3 million of the company's securities in the initial closing of the company's recent private placement.

"We are pleased to have Helen join the Sunesis Board of Directors," said Daniel Swisher, Sunesis' Chief Executive Officer. "Helen brings a wealth of experience in corporate development as well as strategic marketing. We believe Helen's proven leadership, successful business development track record and commercial insights will benefit Sunesis significantly."

Ms. Kim is currently a Director and Chief Executive Officer of privately held TRF Pharma, Inc. Previously, she was the Chief Executive Officer and President of Kosan Biosciences Incorporated where she restructured and repositioned the company prior to successfully selling the company to Bristol-Myers Squibb in 2008. Ms. Kim's additional industry experience includes senior positions at Affymax, Onyx Pharmaceuticals, Protein Design Labs and Chiron Corporation. In addition to her industry experience, Ms. Kim also recently served as Chief Program Officer for the Gordon and Betty Moore Foundation from 2003 to 2008. Ms. Kim received a B.S. in Chemical Engineering from Northwestern University and a M.B.A. from the University of Chicago.

About Sunesis Pharmaceuticals

Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of hematologic and solid cancers. Sunesis has built a highly experienced cancer drug development organiza
'/>"/>

SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
2. Sunesis Pharmaceuticals Reports New Option Grants Under NASDAQ Marketplace Rule 4350
3. Sunesis Pharmaceuticals SNS-595 Shows Clinical Activity in Patients With Relapsed or Refractory Acute Leukemias; Data Presented in Oral Session at 49th Annual Meeting of the American Society of Hematology
4. Sunesis Pharmaceuticals to Present at Healthcare Investor Conferences in March
5. Sunesis Pharmaceuticals Presents Nonclinical Data on SNS-595 at the Annual Meeting of the American Association for Cancer Research
6. Sunesis Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
7. Sunesis Pharmaceuticals to Present at the Collins Stewart Fourth Annual Growth Conference
8. Sunesis Pharmaceuticals Announces Up To $43.5 Million Financing
9. Sunesis Reports Financial Results for the First Quarter 2009
10. Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia and Ovarian Cancer Will Be Presented at ASCO
11. Sunesis Pharmaceuticals Receives Milestone Payment From Biogen Idec
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Dallas, TX (PRWEB) August 21, 2014 ... August 20 entertained residents with dementia at Silverado Turtle ... Improv Troupe, which consists of entertainers ranging from ages ... each time they perform their 40-minute set. The troupe's ... makes it universal and allows them to touch audiences ...
(Date:8/21/2014)... low or very low birth weight may be at ... findings, which appear in Diabetes Care , may ... diabetes in African American populations, which has a high ... University,s Slone Epidemiology Center followed more than 21,000 women ... course of 16 years, analyzing characteristics such as birth ...
(Date:8/21/2014)... 21, 2014 (HealthDay News) -- Not only is eating better ... them hundreds of health-care dollars a year, a new study ... of public health sciences at Wake Forest Baptist Medical Center ... obese type 2 diabetes patients. Participants ranged ... to either an intensive "lifestyle change program" focused on diet ...
(Date:8/21/2014)... Thompson HealthDay Reporter ... of therapy and antidepressants appears to best help people ... Four out of five people suffering from severe ... when treated with cognitive therapy plus antidepressant medication, researchers ... work much better than drugs alone in helping people ...
(Date:8/21/2014)... 21, 2014 A new study published ... increase in disability associated with speech problems from 2001-02 ... than 15% increase in disability associated with hearing problems. ... rising numbers of children who are experiencing communication disorders, ... , On a broader level, the new study, ...
Breaking Medicine News(10 mins):Health News:Unicorn Clearance Improv Troupe Brings Laughter to Residents with Dementia at Silverado Memory Care 2Health News:Low birth weight linked to higher incidence of type 2 diabetes in African American women 2Health News:Getting Healthier a Big Money-Saver for People With Diabetes 2Health News:Talk Therapy Plus Meds May Be Best for Severe Depression 2Health News:Talk Therapy Plus Meds May Be Best for Severe Depression 3Health News:New Pediatrics Study Reveals Dramatic Increase in Speech Problems in Children Over Past Decade 2Health News:New Pediatrics Study Reveals Dramatic Increase in Speech Problems in Children Over Past Decade 3
... some, addiction grabs hold quickly , , MONDAY, Oct. 1 (HealthDay ... drag a teen into smoking addiction, a new study suggests. ... tried smoking said their first cigarette brought them a feeling ... to become smokers. , "This provides further support for the ...
... first study to assess the stability of three aspects ... an increased risk of mortality in short sleep, long ... study published in the October 1 issue of the ... MD, PhD, of the Finnish Institute of Occupational Health ...
... (miRNA), better known for its roles in cancer, could ... HIV, the AIDS virus, evades detection, hiding in the ... have shown that when an individual infected with HIV ... (highly active antiretroviral therapy), the virus calls on miRNAs ...
... have identified a heart protection mechanism in mice that ... improve treatments for patients in future. , The research, ... Critical Care Medicine, was funded by the British Heart ... Physiology at the University of Bristol, and his colleagues ...
... saving lives, experts say , SUNDAY, Sept. 30 (HealthDay ... emergency care system responses to ensure that stroke patients ... So concludes a new policy statement from the American ... reduce the risk of death and disability in stroke ...
... FORT LAUDERDALE, Fla., Sept. 29 The North ... true magnitude of its,experience and commitment to Broward ... a name which truly reflects its,mission. The North ... The collective strength of its talented network of ...
Cached Medicine News:Health News:First Puff Can Turn Kids Into Smokers: Study 2Health News:First Puff Can Turn Kids Into Smokers: Study 3Health News:First Puff Can Turn Kids Into Smokers: Study 4Health News:Both short and long sleep is associated with increased mortality 2Health News:MicroRNAs may be key to HIV's ability to hide, evade drugs, Jefferson scientists find 2Health News:New research suggests hearts are experts at self-preservation 2Health News:Communities Can Speed Stroke Care 2Health News:Broward Health: New Name Draws on Collective Strength of Experience 2
(Date:8/21/2014)... HAMBURG, Germany , Aug. 21, 2014 /PRNewswire/ ... collaborating with Deutsches Elektronen-Synchrotron ( DESY ), a leading ... to speed up management and storage of massive volumes ... Analytics architecture based on IBM software defined technology ... data at peak performance and help scientists worldwide gain ...
(Date:8/21/2014)... -- ACI Clinical ( www.aciclinical.com ) announces a new, ... Using this solution, trial sponsors can save ... and receive the same expertise that has made ... Leveraging a decade of DMC experience (initial ... programming and meeting facilitation), ACI analyzed DMC member ...
(Date:8/21/2014)... WOONSOCKET, R.I. , Aug. 21, 2014 CVS ... early tender results, applicable Reference Yields and consideration payable in ... Offers") commenced on August 7, 2014 for (1) any and ... and All Notes") and (2) up to a maximum amount ... due 2041 and 5.750% Senior Notes due 2017 (collectively, the ...
Breaking Medicine Technology:DESY and IBM Develop Big Data Architecture for Science 2DESY and IBM Develop Big Data Architecture for Science 3ACI Clinical: Innovation and Savings in Data Safety Monitoring Committees 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 3CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 4CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 5CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 6
... Comfort fit large designer ... adjustable strap bridge providing a ... on the nose. The head ... for custom fit. The acrylic ...
... Constructed of optical steel base metal with ... provides enhanced durability. Includes adjustable non-slip silicon ... Metalite comes with custom fitted lead sheet ... the front lenses for increased scatter radiation ...
All New Ultra Pb Series Glasses...
... Stylish and comfortable eye protection Properly ... 90% of scatter radiation. Our high quality ... and comfort with minimized weight. Our lenses ... optics that meet all industry standards. Most ...
Medicine Products: